Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20 , Pages S5-S13 , December 2006

Update on the MA.17 extended adjuvant trial

  • Paul Goss (Director, Breast Cancer Research, Massachusetts General Hospital Cancer Center; Co-Director, Breast Cancer Disease Program, DF/HCC)

      Affiliations

    • Corresponding Author InformationTel.: +1 617 724 3118; Fax: +1 617 724 3166.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(06)00081-9

doi: 10.1016/j.beem.2006.10.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20 , Pages S5-S13 , December 2006

Article Tools

* Image Usage & Resolution